Synergistic Cationic Amphiphilic Polymer Combinations for Enhanced Therapeutic Delivery

This inventive concept integrates cationic amphiphilic polymers with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for co-delivering hydrophobic agents and nucleic acids.

The original patent disclosed cationic amphiphilic polymers for co-delivery of hydrophobic agents and nucleic acids. However, the patent's limitations included the need for more efficient and targeted delivery systems. This inventive concept addresses these limitations by combining the polymers with other technologies to enhance the delivery profile and provide real-time monitoring and verification.

The inventive concept comprises a formulation of cationic amphiphilic polymers, which can be integrated with various technologies to create a synergistic system. For instance, a microfluidic device can be used to control the release of the formulation, while a machine learning algorithm optimizes the release profile. Alternatively, an IoT sensor can be employed to monitor the delivery profile, or a blockchain network can be used to track and verify the delivery. Additionally, the polymers can be combined with nanoclay for controlled release or graphene-based sensors for real-time monitoring. The inventive concept also enables the use of genetic algorithms to identify optimal polymer combinations and 3D printing to fabricate customized delivery devices.

The new claims introduce novel combinations of cationic amphiphilic polymers with distinct technologies, providing an inventive step over the original patent. The integration of these technologies enables real-time monitoring, optimization, and verification of the delivery profile, which is not achievable with the original polymers alone.

Other embodiments of the inventive concept may include the use of different machine learning algorithms, IoT sensors, or blockchain networks. Additionally, the polymers can be combined with other materials, such as nanoparticles or lipids, to enhance the delivery profile. The inventive concept can also be adapted for use in various therapeutic applications, including cancer treatment, gene therapy, or vaccine delivery.

The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the development of targeted and efficient delivery systems for therapeutic compounds. The market for such systems is expected to grow significantly in the coming years, driven by the increasing need for personalized medicine and more effective treatment options.